Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) EPS (Basic) (2016 - 2025)

Veracyte's EPS (Basic) history spans 14 years, with the latest figure at $0.52 for Q4 2025.

  • For Q4 2025, EPS (Basic) rose 642.86% year-over-year to $0.52; the TTM value through Dec 2025 reached $0.84, up 162.5%, while the annual FY2025 figure was $0.84, 162.5% up from the prior year.
  • EPS (Basic) for Q4 2025 was $0.52 at Veracyte, up from $0.24 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.52 in Q4 2025 and bottomed at -$0.66 in Q1 2021.
  • The 5-year median for EPS (Basic) is -$0.12 (2023), against an average of -$0.07.
  • The largest annual shift saw EPS (Basic) plummeted 660.0% in 2023 before it surged 642.86% in 2025.
  • A 5-year view of EPS (Basic) shows it stood at -$0.14 in 2021, then soared by 64.29% to -$0.05 in 2022, then tumbled by 660.0% to -$0.38 in 2023, then surged by 118.42% to $0.07 in 2024, then soared by 642.86% to $0.52 in 2025.
  • Per Business Quant, the three most recent readings for VCYT's EPS (Basic) are $0.52 (Q4 2025), $0.24 (Q3 2025), and -$0.01 (Q2 2025).